pharmaphorum

OCTOBER 1, 2022

With Frontiers Health 2022 mere weeks away, we continue to interview members of the steering committee, gaining insight into what to expect from Milan. We really are saying the ‘health industry’ and that is what gets us up in the morning.”. But he does admit a considerable excitement about Frontiers Health 2022. “I

Doctors 94

Doctors Doctor FDA Approval Pharmacy 94

pharmaphorum

JANUARY 25, 2023

Digital therapeutics company Woebot Health has announced enrolment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational therapeutic for postpartum depression (PPD), granted Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2021.

In-Vivo 98

In-Vivo Clinical Trials Clinical Trials Trials 98

XTalks

JUNE 12, 2023

The transaction, which involves Medtronic contributing its entire Renal Care Solutions (RCS) business to NewCo, is anticipated to close in 2023, pending customary regulatory approvals and closing conditions. These approvals reinforced the company’s position as a global leader in eye health. billion in annual revenue in 2022, a 4.20

FDA Approval 98

FDA Approval Production Sales In-Vitro 98